SMTL ID : 4ot5.1

Crystal structure of BTK kinase domain complexed with 4-tert-Butyl-N-(3-{8-[4-(4-methyl-piperazine-1-carbonyl)-phenylamino]-imidazo[1,2-a]pyrazin-6-yl}-phenyl)-benzamide

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.55 Å

Oligo State

monomer

Ligands

1 x 481: 4-tert-butyl-N-{3-[8-({4-[(4-methylpiperazin-1-yl)carbonyl]phenyl}amino)imidazo[1,2-a]pyrazin-6-yl]phenyl}benzamide(Non-covalent)

481.1: 25 residues within 4Å: Chain A: L.32, G.33, T.34, G.35, Q.36, F.37, V.40, A.52, K.54, T.98, E.99, Y.100, M.101, A.102, N.103, G.104, E.112, D.145, N.150, L.152, D.163, L.166, S.167, V.170, Y.175 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:F.37, A:V.40, A:V.40, A:Y.100, A:L.166, A:V.170, A:Y.175 Hydrogen bonds: A:M.101, A:M.101 Water bridges: A:G.35, A:R.114 Salt bridges: A:E.112

2 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.2: 7 residues within 4Å: Chain A: R.144, P.184, W.187, S.188, V.192, F.198, S.202 2 PLIP interactions: 2 interactions with chain A Water bridges: A:R.144, A:R.144 DMS.3: 6 residues within 4Å: Chain A: R.144, S.167, Y.175, T.176, F.183, F.198 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:S.167

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lou, Y. et al., Structure-Based Drug Design of RN486, a Potent and Selective Bruton's Tyrosine Kinase (BTK) Inhibitor, for the Treatment of Rheumatoid Arthritis. J.Med.Chem. (2015)

Release Date

2014-05-14

Peptides

Tyrosine-protein kinase BTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence